WHO ICTRP trial
Assess safety and efficacy of vilaprisan in subjects with endometriosis
EUCTR2013-004768-72-FI · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-004768-72-FI |
|---|---|
| Public title | Assess safety and efficacy of vilaprisan in subjects with endometriosis |
| Scientific title | A randomized, double-blind, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of two different doses of vilaprisan (BAY 1002670) versus placebo in women with symptomatic endometriosis - Villendo |
| Primary sponsor | Bayer AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Portugal;Taiwan;Finland;Spain;Austria;Switzerland;Italy;Czech Republic;Hungary;Canada;Poland;Denmark;Bulgaria;Germany;China;Japan;Sweden |
| Conditions | Pre-menopausal women 18 years and older with confirmed endometriosis and moderate to severe endometriosis-associated pelvic pain (EAPP), otherwise in good general health. MedDRA version: 20.0 Level: PT Classification code 10014778 Term… |
| Interventions | Product Name: BAY 1002670 coated tablet 2 mg Product Code: BAY 1002670 Pharmaceutical Form: Coated tablet INN or Proposed INN: vilaprisan CAS Number: 1262108-14-4 Current Sponsor code: BAY 1002670 Other descriptive name: BAY 1002670… |
| Registration date | Apr 27, 2018 |
| Target size | 315 |
| Secondary IDs | BAY1002670/15792;2013-004768-72-AT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: